Manuel Plantec

EURASANTE
International Business Development Officer 

Gary Robinson

NIH, NCI, NHLBI, NIDDK, NIAID, NINDS

Raphael Ronen

Sunnybrook Research Institute

Dr. Chris Sasiela

NIH, NCI, NHLBI, NIDDK, NIAID, NINDS
Regulatory Specialist 
BIO

Dr. Sasiela is the Regulatory Specialist for the Office of Translational Alliances and Coordination (OTAC, http://bit.ly/callNHLBIotac) of the National Heart, Lung, and Blood Institute (NHLBI).  In this role she helps NHLBI-funded investigators (academic and small businesses) understand and navigate the US biomedical regulatory pathway through educational events and one-on-one consultation.  Prior to joining the NHLBI, Chris’ regulatory experience includes working in the Office of Biotechnology Products at the FDA, and as Director of Regulatory Affairs and Services at a contracting company.  She earned a Bachelor’s degree in Chemistry from Whittier College; a Ph.D. in Pharmaceutical Science from the University of Maryland Baltimore; and holds a Regulatory Affairs Certification (US) through the Regulatory Affairs Professional Society.

Jackson Streeter

Florida Institute for the Comm. of Public Research

Carolina Torres

AmCham Chile

Dr. Daniela Vaisman Chile

The Center for Biotechnology and Bioengineering is created in 2014, after being selected by the Research Partnership Program of CONICYT to be part of the national program for Basal Funding for Excellence Scientific and Technological Centers.

CeBiB is a Centre of Excellence in cutting-edge research composed by an interdisciplinarian team of renowned national and international scientits, capable of investigating key aspects and current trens in biotechnology and bioengineering, including the research for important applications for industry.

One of the main goals of CeBiB is the research and development of applications to be used in areas where Chile has significant comparative advantages, looking for these areas always in line with the interests of the industry and the needs of the public and private sectors, to increase the competitiveness of the national economy based on scientific and technological innovation.

CeBiB is composed by researchers and academics leaders in their fields from Chilean universities: Universidad de ChileUniversidad de AntofagastaUniversidad de Santiago de ChileUniversidad de La Frontera and Universidad de Los Lagos.

Website:
www.cebib.cl/en/
Diagnostics Subsector
Year Founded
2014
CeBiB
LinkedIn logo Project Engineer 
BIO

Civil engineer in biotechnology, bilingual and graduated from postgraduate programs in the areas of chemistry and biotechnology. Positive, proactive and efficient, with great interest in learning about new areas. With a productive career, focused primarily on biotechnology and the chemical industry; management and innovation, related with the postgraduate studies and with independent projects (production of hyaluronic acid from bacteria; optimization microorganisms cultures; development of a ELISA Kit for salmon; collagen extraction from cuttlefish; Lobesia botrana trap and repellent, CORFO Projects, HibridaLab, Hospital SCM, etc.). A particular training in innovation and entrepreneurship in the last years has allowed to develop the ability to work guiding different interdisciplinary groups, mainly associated with emerging projects and structuring business models. With special interest in the formulation and development of innovation projects within and outside companies, particularly related with the biotechnology industry, health and process engineering.

Dr rer Nat Sofia Valenzuela Chile

DiagnoChrome is a spin-off company of the Biotechnology Center at the Universidad de Concepcion, Chile. La company develops kits for the diagnostics of plant pathogens, being our first kit the detection of Botrytis cinerea in bluberries. 

Diagnostics Subsector
Indication
Year Founded
2016
CB UdeC- DiagnoChrome
Professor- Deputy Director 
BIO

Biochemst from the Universidad de Chile, and dr rer Nat at TU Braunschweig, Germany. Currently Deputy Director of the Biotechnology Center and professor at the Forest Science Faculty at the Universidad de Concepcion Chile. Main area of R&D&i genomics and biosafety of GMOs. PI of several R&D proposals with companies, in the area of forest genomics. 

Have been co-founder of two spin-offs Genomica Forestal and DiagnoChrome. The latter focused on the development of detection kits for plant pathogens. 

John Walter

Alliance For Cancer Gene Therapy
CEO & President 

Ms. Wenyi Zhu United States

US China Innovation Alliance is a non-profit 501c3 tax-exempt corporation that aims to provide a platform to promote exchange and collaboration in innovation between China and U.S. UCIA organizes annual US China Innovation and Investment Summit (UCIS) with 3 missions: 1) facilitate collaboration among venture capitals, accelerators and incubators from both countries, 2) help Chinese investors reach and invest in the latest technologies and products in U.S and 3) help U.S. technology startups find capital and partners from China, as well as enter China market. UCIA also organizes U.S. technology company roadshow in China and US China business plan competition and other activities to help US technology companies connect with China resources.

Find INVESTOR for your HEALTHCARE STARTUP- Join our 2016 healthcare roadshow to raise fund, find partnerships in licensing, clinical trial, manufacturing,or marketing! For Detailshttps://drive.google.com/drive/u/0/folders/0B8vXixB-4G48bldwalJnWkFfblU   For Registration - https://www.eventbrite.com/e/ucia-healthcare-technology-roadshow-in-china-tickets-27080151462?aff=eandprexshre&ref=eandprexshre

US-China Innovation Alliance
LinkedIn logo Project Lead  
BIO

Consultant | B2B Matchmating | US to China | Investment